Company information:
Roquefort Therapeutics Plc (No: 12819145)
Address: 85 GREAT PORTLAND STREET, FIRST FLOOR, LONDON, W1W 7LT, ENGLAND
Status: Operating Company
Incorporated: 17-Aug-2020
Accounts Next Due: 30-Jun-2024
Next Confirmation Statement Due: 30-Aug-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: DARRIN MATTHEW DISLEY ( DOB: Jul-1967 From: Sep-2022 )
Current Director: JEAN MARIE DUVALL ( DOB: Jun-1961 From: Apr-2022 )
Current Director: MARTIN JOHN EVANS ( DOB: Jan-1941 From: Sep-2022 )
Current Director: MARTIN JOHN EVANS ( DOB: Jan-1941 From: Sep-2022 )
Current Director: TREVOR AJAN REGINALD ( DOB: Feb-1972 From: Sep-2022 )
Current Director: SIMON RUPERT SINCLAIR ( DOB: May-1972 From: Apr-2022 )
Current Director: STEPHEN PAUL WEST ( DOB: Oct-1972 From: Aug-2020 )
Current Secretary: ORANA CORPORATE LLP ( From: Dec-2021 )
Current Secretary: ORANA CORPORATE LLP ( From: Dec-2021 )
Resigned Director: MARK FREEMAN ( DOB: Jul-1975 From: Oct-2021 To: Sep-2022 )
Resigned Director: MARK ANDREW ROLLINS ( DOB: May-1964 From: Nov-2020 To: Apr-2022 )
Resigned Director: MICHAEL LEWIS STEIN ( DOB: May-1963 From: Mar-2021 To: May-2024 )
Resigned Director: GLENN ROSS WHIDDON ( DOB: May-1964 From: Aug-2020 To: Oct-2021 )
Resigned Secretary: STEPHEN PAUL WEST ( From: Aug-2020 To: Dec-2021 )
Persons of Significant Control:
Mr Glenn Ross Whiddon, Eccleston Yards 25 Eccleston Place, London, SW1W 9NF, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2020-08-17, Ceased: 2021-03-22)
Mr Stephen Paul West, Eccleston Yards 25 Eccleston Place, London, SW1W 9NF, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2020-08-17, Ceased: 2021-03-22)